rs2660169

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_033056.4(PCDH15):​c.2751+43C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0676 in 1,546,326 control chromosomes in the GnomAD database, including 11,783 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.17 ( 4755 hom., cov: 32)
Exomes 𝑓: 0.057 ( 7028 hom. )

Consequence

PCDH15
NM_033056.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 0.0520

Publications

4 publications found
Variant links:
Genes affected
PCDH15 (HGNC:14674): (protocadherin related 15) This gene is a member of the cadherin superfamily. Family members encode integral membrane proteins that mediate calcium-dependent cell-cell adhesion. It plays an essential role in maintenance of normal retinal and cochlear function. Mutations in this gene result in hearing loss and Usher Syndrome Type IF (USH1F). Extensive alternative splicing resulting in multiple isoforms has been observed in the mouse ortholog. Similar alternatively spliced transcripts are inferred to occur in human, and additional variants are likely to occur. [provided by RefSeq, Dec 2008]
PCDH15 Gene-Disease associations (from GenCC):
  • autosomal recessive nonsyndromic hearing loss 23
    Inheritance: AR Classification: DEFINITIVE, STRONG, LIMITED Submitted by: Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), PanelApp Australia
  • Usher syndrome type 1
    Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • Usher syndrome type 1F
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), PanelApp Australia
  • hearing loss, autosomal recessive
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • nonsyndromic genetic hearing loss
    Inheritance: AR Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BP6
Variant 10-54020149-G-C is Benign according to our data. Variant chr10-54020149-G-C is described in ClinVar as Benign. ClinVar VariationId is 262148.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.452 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PCDH15NM_033056.4 linkc.2751+43C>G intron_variant Intron 20 of 32 ENST00000320301.11 NP_149045.3 Q96QU1-1
PCDH15NM_001384140.1 linkc.2751+43C>G intron_variant Intron 20 of 37 ENST00000644397.2 NP_001371069.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PCDH15ENST00000320301.11 linkc.2751+43C>G intron_variant Intron 20 of 32 1 NM_033056.4 ENSP00000322604.6 Q96QU1-1
PCDH15ENST00000644397.2 linkc.2751+43C>G intron_variant Intron 20 of 37 NM_001384140.1 ENSP00000495195.1 A0A2R8Y6C0

Frequencies

GnomAD3 genomes
AF:
0.166
AC:
25218
AN:
151844
Hom.:
4731
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.457
Gnomad AMI
AF:
0.0417
Gnomad AMR
AF:
0.0862
Gnomad ASJ
AF:
0.0545
Gnomad EAS
AF:
0.262
Gnomad SAS
AF:
0.154
Gnomad FIN
AF:
0.0276
Gnomad MID
AF:
0.127
Gnomad NFE
AF:
0.0308
Gnomad OTH
AF:
0.133
GnomAD2 exomes
AF:
0.0941
AC:
23292
AN:
247406
AF XY:
0.0900
show subpopulations
Gnomad AFR exome
AF:
0.464
Gnomad AMR exome
AF:
0.0476
Gnomad ASJ exome
AF:
0.0536
Gnomad EAS exome
AF:
0.254
Gnomad FIN exome
AF:
0.0281
Gnomad NFE exome
AF:
0.0295
Gnomad OTH exome
AF:
0.0688
GnomAD4 exome
AF:
0.0568
AC:
79222
AN:
1394364
Hom.:
7028
Cov.:
23
AF XY:
0.0583
AC XY:
40711
AN XY:
697856
show subpopulations
African (AFR)
AF:
0.473
AC:
15155
AN:
32056
American (AMR)
AF:
0.0506
AC:
2247
AN:
44414
Ashkenazi Jewish (ASJ)
AF:
0.0540
AC:
1387
AN:
25696
East Asian (EAS)
AF:
0.255
AC:
10023
AN:
39234
South Asian (SAS)
AF:
0.150
AC:
12757
AN:
84894
European-Finnish (FIN)
AF:
0.0290
AC:
1526
AN:
52550
Middle Eastern (MID)
AF:
0.0794
AC:
447
AN:
5630
European-Non Finnish (NFE)
AF:
0.0292
AC:
30751
AN:
1051726
Other (OTH)
AF:
0.0847
AC:
4929
AN:
58164
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
3704
7408
11113
14817
18521
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1566
3132
4698
6264
7830
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.166
AC:
25291
AN:
151962
Hom.:
4755
Cov.:
32
AF XY:
0.165
AC XY:
12263
AN XY:
74290
show subpopulations
African (AFR)
AF:
0.457
AC:
18938
AN:
41416
American (AMR)
AF:
0.0861
AC:
1312
AN:
15244
Ashkenazi Jewish (ASJ)
AF:
0.0545
AC:
189
AN:
3468
East Asian (EAS)
AF:
0.262
AC:
1354
AN:
5166
South Asian (SAS)
AF:
0.154
AC:
743
AN:
4820
European-Finnish (FIN)
AF:
0.0276
AC:
292
AN:
10596
Middle Eastern (MID)
AF:
0.133
AC:
39
AN:
294
European-Non Finnish (NFE)
AF:
0.0308
AC:
2093
AN:
67930
Other (OTH)
AF:
0.138
AC:
293
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
815
1630
2445
3260
4075
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
238
476
714
952
1190
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0409
Hom.:
113
Bravo
AF:
0.183
Asia WGS
AF:
0.240
AC:
831
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Jun 16, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.85
CADD
Benign
1.7
DANN
Benign
0.46
PhyloP100
0.052
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2660169; hg19: chr10-55779909; COSMIC: COSV57389215; API